Programme :
Presentations by Room
Conference Hall Track 1
Tuesday, 23 February 2021
| Immunology and revolution | |||||
|
Tue23 Feb09:35am(45 mins)
|
|
Prof Richard Cornall | |||
|
Track : Plenary Keynote
Room: Conference Hall Track 1
|
|||||
| Franklin and factor of 10 opportunities | |||||
|
Tue23 Feb11:15am(20 mins)
|
|
Prof Jim Naismith | |||
|
Room: Conference Hall Track 1
|
|||||
| New developments in the analysis of molecular interactions using NMR spectroscopy | |||||
|
Tue23 Feb11:35am(20 mins)
|
|
Dr Christopher Waudby | |||
|
Room: Conference Hall Track 1
|
|||||
| Native Mass spectrometry as a novel drug discovery method for membrane proteins | |||||
|
Tue23 Feb12:00pm(20 mins)
|
|
Ali Jazayeri | |||
|
Room: Conference Hall Track 1
|
|||||
|
Tue23 Feb12:40pm(5 mins)
|
Nexcelom Bioscience Ltd |
| 3D Electron Diffraction Methods for Crystal Structure Determination - from Materials to Proteins | |||||
|
Tue23 Feb02:15pm(20 mins)
|
|
Hongyi Xu | |||
|
Room: Conference Hall Track 1
|
|||||
| TBC | |||||
|
Tue23 Feb02:50pm(20 mins)
|
|
Chun-wa Chung | |||
|
Room: Conference Hall Track 1
|
|||||
| Expanding the industrial structural biologist's toolkit with cryo-EM | |||||
|
Tue23 Feb03:15pm(20 mins)
|
|
Dr Judith Reeks | |||
|
Room: Conference Hall Track 1
|
|||||
Wednesday, 24 February 2021
| Empowering Drug Discovery through Genomics | |||||
|
Wed24 Feb09:35am(45 mins)
|
|
Sir Peter Donnelly | |||
|
Track : Plenary Keynote
Room: Conference Hall Track 1
|
|||||
| Drug discovery for Alzheimer’s disease – Challenges and Opportunities | |||||
|
Wed24 Feb10:55am(15 mins)
|
|
Dr Magnus Walter | |||
|
Room: Conference Hall Track 1
|
|||||
|
Wed24 Feb11:15am(15 mins)
|
Psychiatry Consortium Title - ‘Accelerating innovative drug discovery in psychiatry: an introduction to the Psychiatry Consortium’ Presenter - Dr Laura Ajram, Psychiatry Consortium Programme Manager Abstract - The scale and impact of mental illness across society is huge and new treatments are needed urgently. However, the lack of novel drug targets combined with the challenge of validating them pre-clinically, and the high failure rate in clinical trials have led to a reduced investment in drug discovery and development in the last decade and there have been no new effective types of treatment for over 30 years. The Psychiatry Consortium is a strategic collaboration of leading medical research charities and pharmaceutical companies, working together to develop and deliver a portfolio of innovative and collaborative projects, which focus on identifying and validating novel drug targets for psychiatric diseases. Collectively, the strategic partners aim to provide approximately £4 million in research funding over three years, to deliver up to 10 high-value drug discovery projects. The Consortium is managed by the Medicines Discovery Catapult and supported by Wellcome. The Psychiatry Consortium is currently seeking project proposals which focus on the validation of novel molecular drug targets for mental health conditions. For successful applicants, in addition to project funding, we provide project management and delivery support and access to industry and commercialisation know-how. This short talk will provide a brief introduction to the Psychiatry Consortium, details of opportunities for funding and information on how to apply. |
| Modelling and understanding dementia using stem cell-derived neurons | |||||
|
Wed24 Feb11:30am(20 mins)
|
|
Charlie Arber | |||
|
Room: Conference Hall Track 1
|
|||||
| TBC | |||||
|
Wed24 Feb11:55am(20 mins)
|
|
Alejo Nevado-holgado | |||
|
Room: Conference Hall Track 1
|
|||||
|
Wed24 Feb12:35pm(5 mins)
|
Iota Sciences |
|
Wed24 Feb12:40pm(15 mins)
|
Promega UK Ltd |
|
Wed24 Feb12:55pm(5 mins)
|
Nexcelom Bioscience Ltd |
| TBC | |||||
|
Wed24 Feb02:05pm(20 mins)
|
|
Steven Lee | |||
|
Room: Conference Hall Track 1
|
|||||
| Transforming drug target discovery through an integrated genomics approach | |||||
|
Wed24 Feb02:25pm(20 mins)
|
|
Dr Dirk Paul | |||
|
Room: Conference Hall Track 1
|
|||||
| TBC | |||||
|
Wed24 Feb02:50pm(20 mins)
|
|
Dr Ultan McDermott | |||
|
Room: Conference Hall Track 1
|
|||||
| Chemical Biology Approaches for Target Identification and Validation | |||||
|
Wed24 Feb03:10pm(15 mins)
|
|
Kilian Huber | |||
|
Room: Conference Hall Track 1
|
|||||
Programme
Hosted By
ELRIG
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
going to the appstore or google play and search for 'elrig'
